Patents
Literature
35 results about "Netilmicin" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Netilmicin is a member of the aminoglycoside family of antibiotics. These antibiotics have the ability to kill a wide variety of bacteria. Netilmicin is not absorbed from the gut and is therefore only given by injection or infusion. It is only used in the treatment of serious infections particularly those resistant to gentamicin.
Use of compounds against coronavirus
Provided is the application of a compound in anti-coronavirus. The application is the application of a compound or a pharmaceutically acceptable salt thereof, a solvate thereof, a solvate of a pharmaceutically acceptable salt thereof, or a crystal form thereof in the preparation of an anti-coronavirus preparation, wherein the compound is selected from one or more of gossypol acetic acid, mecobalamin, ertapenem, chaetocidin, netilmicin sulfate, sennoside A and ellagic acid. In the application, the compound can effectively inhibit coronavirus RNA-dependent RNA polymerase (RDRP), thereby inhibiting the proliferation of coronavirus and being applied to anti-coronavirus. The inhibition effect is strong, the cost is low, and the required dose is small, and the compound can be effectively used in anti-coronavirus.
Owner:SHANGHAI TECH UNIV